{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:51:29Z","timestamp":1787003489120,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["G101107"],"award-info":[{"award-number":["G101107"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009795","name":"Pancreatic Cancer UK","doi-asserted-by":"publisher","award":["G109884"],"award-info":[{"award-number":["G109884"]}],"id":[{"id":"10.13039\/100009795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009795","name":"Pancreatic Cancer UK","doi-asserted-by":"publisher","award":["G109884"],"award-info":[{"award-number":["G109884"]}],"id":[{"id":"10.13039\/100009795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Emerging evidence suggests that lineage-specifying transcription factors control the progression of pancreatic ductal adenocarcinoma (PDAC). We have discovered a transcription factor switching mechanism involving the poorly characterized orphan nuclear receptor HNF4G and the putative pioneer factor FOXA1, which drives PDAC progression. Using our unbiased protein interactome discovery approach, we identified HNF4A and HNF4G as reproducible, FOXA1-associated proteins, in both preclinical models and Whipple surgical samples. In the primary tumor context, we consistently find that the dominant transcription factor is HNF4G, where it functions as the driver. A molecular switch occurs in advanced disease, whereby HNF4G expression or activity decreases, unmasking FOXA1\u2019s transcriptional potential. Derepressed FOXA1 drives late-stage disease by orchestrating metastasis-specific enhancer\u2013promoter loops to regulate the expression of metastatic genes. Overall survival is influenced by HNF4G and FOXA1 activity in primary tumor growth and in metastasis, respectively. We suggest that the existence of stage-dependent transcription factor activity, triggered by molecular compartmentalization, mediates the progression of PDAC.<\/jats:p>","DOI":"10.1038\/s41588-025-02389-7","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:04:33Z","timestamp":1761818673000},"page":"3016-3026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transcription factor switching drives subtype-specific pancreatic cancer"],"prefix":"10.1038","volume":"57","author":[{"given":"Shalini V.","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danya","family":"Cheeseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5774-5036","authenticated-orcid":false,"given":"Dominique-Laurent","family":"Couturier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Brais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Temple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5835-2055","authenticated-orcid":false,"given":"Evangelia","family":"Papachristou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7039-2922","authenticated-orcid":false,"given":"Catarina","family":"Pelicano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Sekhar Reddy","family":"Chilamakuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Herka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luay","family":"Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis F.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Siveke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Guerrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4169-5446","authenticated-orcid":false,"given":"Luca","family":"Insolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Archer Goode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Kupczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0584-5737","authenticated-orcid":false,"given":"Giacomo","family":"Borsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9360-1670","authenticated-orcid":false,"given":"Duncan","family":"Jodrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"D\u2019Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara T.","family":"Gr\u00fcnwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Serrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Chernukhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3643-0080","authenticated-orcid":false,"given":"Jason S.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"2389_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature11547","volume":"491","author":"AV Biankin","year":"2012","unstructured":"Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399\u2013405 (2012).","journal-title":"Nature"},{"key":"2389_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47\u201352 (2016).","journal-title":"Nature"},{"key":"2389_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1053\/j.gastro.2016.09.060","volume":"152","author":"JL Humphris","year":"2017","unstructured":"Humphris, J. L. et al. Hypermutation in pancreatic cancer. Gastroenterology 152, 68\u201374 (2017).","journal-title":"Gastroenterology"},{"key":"2389_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495\u2013501 (2015).","journal-title":"Nature"},{"key":"2389_CR5","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168\u20131178 (2015).","journal-title":"Nat. Genet."},{"key":"2389_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/emboj\/17.1.244","volume":"17","author":"LA Cirillo","year":"1998","unstructured":"Cirillo, L. A. et al. Binding of the winged-helix transcription factor HNF3 to a linker histone site on the nucleosome. EMBO J. 17, 244\u2013254 (1998).","journal-title":"EMBO J."},{"key":"2389_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1097-2765(02)00459-8","volume":"9","author":"LA Cirillo","year":"2002","unstructured":"Cirillo, L. A. et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 9, 279\u2013289 (2002).","journal-title":"Mol. Cell"},{"key":"2389_CR8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/ng.3419","volume":"47","author":"MM Pomerantz","year":"2015","unstructured":"Pomerantz, M. M. et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat. Genet. 47, 1346\u20131351 (2015).","journal-title":"Nat. Genet."},{"key":"2389_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng.730","volume":"43","author":"A Hurtado","year":"2011","unstructured":"Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D. & Carroll, J. S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 43, 27\u201333 (2011).","journal-title":"Nat. Genet."},{"key":"2389_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cell.2017.07.007","volume":"170","author":"JS Roe","year":"2017","unstructured":"Roe, J. S. et al. Enhancer reprogramming promotes pancreatic cancer metastasis. Cell 170, 875\u2013888 (2017).","journal-title":"Cell"},{"key":"2389_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41588-019-0384-0","volume":"51","author":"L Chen","year":"2019","unstructured":"Chen, L. et al. A reinforcing HNF4\u2013SMAD4 feed-forward module stabilizes enterocyte identity. Nat. Genet. 51, 777\u2013785 (2019).","journal-title":"Nat. Genet."},{"key":"2389_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107625","volume":"31","author":"H Brunton","year":"2020","unstructured":"Brunton, H., et al. HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer. Cell Rep. 31, 107625 (2020).","journal-title":"Cell Rep."},{"key":"2389_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2013.25","volume":"2","author":"T Okegawa","year":"2013","unstructured":"Okegawa, T., Ushio, K., Imai, M., Morimoto, M. & Hara, T. Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 gene. Oncogenesis 2, e58 (2013).","journal-title":"Oncogenesis"},{"key":"2389_CR14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ccell.2017.10.008","volume":"32","author":"S Shukla","year":"2017","unstructured":"Shukla, S. et al. Aberrant activation of a gastrointestinal transcriptional circuit in prostate cancer mediates castration resistance. Cancer Cell 32, 792\u2013806 (2017).","journal-title":"Cancer Cell"},{"key":"2389_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s13238-020-00760-4","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Metformin inhibits pancreatic cancer metastasis caused by SMAD4 deficiency and consequent HNF4G upregulation. Protein Cell 12, 128\u2013144 (2021).","journal-title":"Protein Cell"},{"key":"2389_CR16","doi-asserted-by":"publisher","first-page":"18018","DOI":"10.18632\/oncotarget.22933","volume":"9","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Expression of HNF4G and its potential functions in lung cancer. Oncotarget 9, 18018\u201318028 (2018).","journal-title":"Oncotarget"},{"key":"2389_CR17","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1007\/s12094-022-03048-7","volume":"25","author":"J Zhan","year":"2023","unstructured":"Zhan, J., Zhang, Q., Tong, X., Liu, X. & Zhao, C. HNF4G stimulates the development of pancreatic cancer by promoting IGF2BP2 transcription. Clin. Transl. Oncol. 25, 1472\u20131481 (2023).","journal-title":"Clin. Transl. Oncol."},{"key":"2389_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02942-5","volume":"9","author":"AP Klein","year":"2018","unstructured":"Klein, A. P. et al. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nat. Commun. 9, 556 (2018).","journal-title":"Nat. Commun."},{"key":"2389_CR19","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1158\/1541-7786.MCR-13-0454","volume":"11","author":"H Mohammed","year":"2013","unstructured":"Mohammed, H. & Carroll, J. S. Approaches for assessing and discovering protein interactions in cancer. Mol. Cancer Res. 11, 1295\u20131302 (2013).","journal-title":"Mol. Cancer Res."},{"key":"2389_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nprot.2016.020","volume":"11","author":"H Mohammed","year":"2016","unstructured":"Mohammed, H. et al. Rapid immunoprecipitation mass spectrometry of endogenous proteins (RIME) for analysis of chromatin complexes. Nat. Protoc. 11, 316\u2013326 (2016).","journal-title":"Nat. Protoc."},{"key":"2389_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04619-5","volume":"9","author":"EK Papachristou","year":"2018","unstructured":"Papachristou, E. K. et al. A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes. Nat. Commun. 9, 2311 (2018).","journal-title":"Nat. Commun."},{"key":"2389_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500 (2011).","journal-title":"Nat. Med."},{"key":"2389_CR23","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1136\/gutjnl-2015-311256","volume":"66","author":"P Martinelli","year":"2017","unstructured":"Martinelli, P. et al. GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Gut 66, 1665\u20131676 (2017).","journal-title":"Gut"},{"key":"2389_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","volume":"52","author":"M Chan-Seng-Yue","year":"2020","unstructured":"Chan-Seng-Yue, M. et al. Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Nat. Genet. 52, 231\u2013240 (2020).","journal-title":"Nat. Genet."},{"key":"2389_CR25","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1039\/D3CC00954H","volume":"59","author":"L Isigkeit","year":"2023","unstructured":"Isigkeit, L. & Merk, D. Opportunities and challenges in targeting orphan nuclear receptors. Chem. Commun. (Camb.) 59, 4551\u20134561 (2023).","journal-title":"Chem. Commun. (Camb.)"},{"key":"2389_CR26","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S0969-2126(02)00829-8","volume":"10","author":"GB Wisely","year":"2002","unstructured":"Wisely, G. B. et al. Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure 10, 1225\u20131234 (2002).","journal-title":"Structure"},{"key":"2389_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24798-y","volume":"12","author":"V Giuliani","year":"2021","unstructured":"Giuliani, V. et al. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. Nat. Commun. 12, 4626 (2021).","journal-title":"Nat. Commun."},{"key":"2389_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","volume":"7","author":"SR Hingorani","year":"2005","unstructured":"Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469\u2013483 (2005).","journal-title":"Cancer Cell"},{"key":"2389_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bbrc.2017.01.051","volume":"484","author":"MJ Binker-Cosen","year":"2017","unstructured":"Binker-Cosen, M. J. et al. Palmitic acid increases invasiveness of pancreatic cancer cells AsPC-1 through TLR4\/ROS\/NF-\u03baB\/MMP-9 signaling pathway. Biochem. Biophys. Res. Commun. 484, 152\u2013158 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2389_CR30","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1053\/j.gastro.2019.11.031","volume":"158","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. HNF4 regulates fatty acid oxidation and is required for renewal of intestinal stem cells in mice. Gastroenterology 158, 985\u2013999 (2020).","journal-title":"Gastroenterology"},{"key":"2389_CR31","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019102808","volume":"39","author":"M Kalisz","year":"2020","unstructured":"Kalisz, M. et al. HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer. EMBO J. 39, e102808 (2020).","journal-title":"EMBO J."},{"key":"2389_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S1097-2765(00)80225-7","volume":"4","author":"LA Cirillo","year":"1999","unstructured":"Cirillo, L. A. & Zaret, K. S. An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA. Mol. Cell 4, 961\u2013969 (1999).","journal-title":"Mol. Cell"},{"key":"2389_CR33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.cell.2008.01.018","volume":"132","author":"M Lupien","year":"2008","unstructured":"Lupien, M. et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132, 958\u2013970 (2008).","journal-title":"Cell"},{"key":"2389_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1501473","volume":"2","author":"G Zhang","year":"2016","unstructured":"Zhang, G. et al. FOXA1 defines cancer cell specificity. Sci. Adv. 2, e1501473 (2016).","journal-title":"Sci. Adv."},{"key":"2389_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature10730","volume":"481","author":"CS Ross-Innes","year":"2012","unstructured":"Ross-Innes, C. S. et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481, 389\u2013393 (2012).","journal-title":"Nature"},{"key":"2389_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108776","volume":"34","author":"R Broome","year":"2021","unstructured":"Broome, R. et al. TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions. Cell Rep. 34, 108776 (2021).","journal-title":"Cell Rep."},{"key":"2389_CR37","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.celrep.2016.11.028","volume":"17","author":"KM Jozwik","year":"2016","unstructured":"Jozwik, K. M., Chernukhin, I., Serandour, A. A., Nagarajan, S. & Carroll, J. S. FOXA1 directs H3K4 monomethylation at enhancers via recruitment of the methyltransferase MLL3. Cell Rep. 17, 2715\u20132723 (2016).","journal-title":"Cell Rep."},{"key":"2389_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cell.2005.05.008","volume":"122","author":"JS Carroll","year":"2005","unstructured":"Carroll, J. S. et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122, 33\u201343 (2005).","journal-title":"Cell"},{"key":"2389_CR39","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nprot.2016.020","volume":"11","author":"H Mohammed","year":"2016","unstructured":"Mohammed, H. et al. Rapid immunoprecipitation mass spectrometry of endogenous proteins (RIME) for analysis of chromatin complexes. Nat. Protoc. 11, 316 (2016).","journal-title":"Nat. Protoc."},{"key":"2389_CR40","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"},{"key":"2389_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ccell.2020.06.007","volume":"38","author":"R Siersb\u00e6k","year":"2020","unstructured":"Siersb\u00e6k, R. et al. IL6\/STAT3 signaling hijacks estrogen receptor \u03b1 enhancers to drive breast cancer metastasis. Cancer Cell 38, 412\u2013423 (2020).","journal-title":"Cancer Cell"},{"key":"2389_CR42","unstructured":"Stark, R. & Brown, G. DiffBind: differential binding analysis of ChIP\u2013seq peak data. bioconductor.org\/packages\/release\/bioc\/html\/DiffBind.html (2011)."},{"key":"2389_CR43","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces, M. R. et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat. Methods 14, 959\u2013962 (2017).","journal-title":"Nat. Methods"},{"key":"2389_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nmeth.4583","volume":"15","author":"CA Lareau","year":"2018","unstructured":"Lareau, C. A. & Aryee, M. J. Hichipper: a preprocessing pipeline for calling DNA loops from HiChIP data. Nat. Methods 15, 155\u2013156 (2018).","journal-title":"Nat. Methods"},{"key":"2389_CR45","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nmeth.3999","volume":"13","author":"MR Mumbach","year":"2016","unstructured":"Mumbach, M. R. et al. HiChIP: efficient and sensitive analysis of protein-directed genome architecture. Nat. Methods 13, 919\u2013922 (2016).","journal-title":"Nat. Methods"},{"key":"2389_CR46","doi-asserted-by":"publisher","first-page":"dmm034793","DOI":"10.1242\/dmm.034793","volume":"11","author":"DJ Erstad","year":"2018","unstructured":"Erstad, D. J. et al. Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. Dis. Model Mech. 11, dmm034793 (2018).","journal-title":"Dis. Model Mech."},{"key":"2389_CR47","doi-asserted-by":"publisher","unstructured":"Couturier, D. L. et al. CarrollLab: transcription factor switching drives progression of the classical subtype of pancreatic cancer (v1.0). Zenodo https:\/\/doi.org\/10.5281\/zenodo.16925967 (2025).","DOI":"10.5281\/zenodo.16925967"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02389-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02389-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02389-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T19:02:13Z","timestamp":1765393333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02389-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2389"],"URL":"https:\/\/doi.org\/10.1038\/s41588-025-02389-7","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"17 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.S.C. has received past research funding from AstraZeneca, which is unrelated to this work. J.S. receives honoraria as a consultant or for continuing medical education presentations from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Immunocore, MSD, Novartis, Roche\/Genentech and Servier. His institution receives research funding from Abalos Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eisbach Bio and Roche\/Genentech; he holds ownership in FAPI Holding (3%); all are unrelated to the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}